Gene · 58508
Papers4,204
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 4,204
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Somatic mutations reveal complex metastatic seeding from multifocal primary prostate cancer. | Int J Cancer | 2023 | 35880692 | PubTator, text mining | PubMed |
| KMT2C Induced by FABP5P3 Aggravates Keratinocyte Hyperproliferation and Psoriasiform Skin Inflammation by Upregulating the Transcription of PIK3R3. | J Invest Dermatol | 2023 | 35870559 | PubTator, text mining | PubMed |
| A Multicentre Clinical Study of Sarcoma Personalised Treatment Using Patient-Derived Tumour Xenografts. | Clin Oncol (R Coll Radiol) | 2023 | 35781406 | PubTator, text mining | PubMed |
| Multiomics identifies the link between intratumor steatosis and the exhausted tumor immune microenvironment in hepatocellular carcinoma. | Hepatology | 2023 | 35567547 | PubTator, text mining | PubMed |
| Focal structural variants revealed by whole genome sequencing disrupt the histone demethylase KDM4C in B-cell lymphomas. | Haematologica | 2023 | 35522148 | PubTator, text mining | PubMed |
| Exosomal proteomics in kidney disease: From technical approaches to clinical applications. | J Food Drug Anal | 2022 | 39666305 | PubTator, text mining | PubMed |
| Evolution and dysfunction of human cognitive and social traits: A transcriptional regulation perspective. | Evol Hum Sci | 2022 | 37588924 | PubTator, text mining | PubMed |
| Malignant melanotic nerve sheath tumor with PRKAR1A, KMT2C, and GNAQ mutations. | Free Neuropathol | 2022 | 37284154 | PubTator, text mining | PubMed |
| A Phenogenetic Axis that Modulates Clinical Manifestation and Predicts Treatment Outcome in Primary Myeloid Neoplasms. | Cancer Res Commun | 2022 | 36873623 | PubTator, text mining | PubMed |
| Whole genome sequencing of Malaysian colorectal cancer patients reveals specific druggable somatic mutations. | Front Mol Biosci | 2022 | 36866106 | PubTator, text mining | PubMed |
| Racial disparities in the genetic landscape of lung cancer. | Cancer Health Disparities | 2022 | 36819657 | PubTator, text mining | PubMed |
Comprehensive genomic profiling of upper tract urothelial carcinoma and urothelial carcinoma of the bladder identifies distinct molecular characterizations with potential implications for targeted therapy & immunotherapy. | Front Immunol | 2022 | 36818471 | PubTator, text mining | PubMed |
| Overexpression of PKMYT1 associated with poor prognosis and immune infiltration may serve as a target in triple-negative breast cancer. | Front Oncol | 2022 | 36793346 | PubTator, text mining | PubMed |
| Lysine methyltransferase Kmt2d regulates naive CD8+ T cell activation-induced survival. | Front Immunol | 2022 | 36741385 | PubTator, text mining | PubMed |
| Unusual phylogenetic tree and circulating actionable ESR1 mutations in an aggressive luminal/HER2-low breast cancer: Case report. | Front Oncol | 2022 | 36713585 | PubTator, text mining | PubMed |
| Angiogenesis-related gene signatures reveal the prognosis of cervical cancer based on single cell sequencing and co-expression network analysis. | Front Cell Dev Biol | 2022 | 36712973 | PubTator, text mining | PubMed |
| Molecular profiling of urinary extracellular vesicles in chronic kidney disease and renal fibrosis. | Front Pharmacol | 2022 | 36712680 | PubTator, text mining | PubMed |
| [Clinical analysis of 20 cases of small B lymphocyte proliferative disease with t (14;19) (q32;q13)]. | Zhonghua Xue Ye Xue Za Zhi | 2022 | 36709153 | PubTator, text mining | PubMed |
| Whole-genome characterization of large-cell lung carcinoma: A comparative analysis based on the histological classification. | Front Genet | 2022 | 36685819 | PubTator, text mining | PubMed |
| Bibliometric analysis of scientific papers on extracellular vesicles in kidney disease published between 1999 and 2022. | Front Cell Dev Biol | 2022 | 36684427 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/58508/papers?page=45